Trial Profile
Double-blind,Randomized, Placebo-controlled, Phase II Dose-finding Study Comparing Different Doses of Norursodeoxycholic Acid Capsules With Placebo in the Treatment of Primary Sclerosing Cholangitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Norursodeoxycholic acid (Primary)
- Indications Primary sclerosing cholangitis
- Focus Therapeutic Use
- Acronyms NUC-3
- Sponsors Dr Falk Pharma
- 08 Dec 2018 This trail has been completed in United Kingdom.
- 02 Apr 2016 Status changed from recruiting to completed, according to European Clinical Trials Database record.
- 16 Dec 2015 New trial record